01.
Nature Medicine
2026-06-19
Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
Authors:
No abstract for this item (typically a correction, editorial or news piece — the publisher provides none)